A Multicenter, Randomized, Placebo-controlled, Double-blind Phase 2 Study of SHR0302 versus Placebo in Chinese Subjects with Moderate to Severe Active Rheumatoid Arthritis (RA)

Zeng, XF; Jiang, Y; Yang, Y; Li, HY

ARTHRITIS & RHEUMATOLOGY, 2020; 72 ():